1-2 of 2
William Blum
Close
Sort by
Journal Articles

How Much? How Frequent? How Long? A Clinical Guide to New Therapies in Myelodysplastic Syndromes

William Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 314–321.
https://doi.org/10.1182/asheducation-2010.1.314
Published: 2010
Journal Articles

Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?

Mark A. Schroeder, William Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 322–324.
https://doi.org/10.1182/asheducation-2010.1.322
Published: 2010